← Leaderboards
Matthew James Magee
Emory University
$4,633,632
Attributed
$5,830,376
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2018–25$2M$1.5M$1M$500K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,830,376 · 6
By mechanism
R01$4,515,103 · 2
R21$1,157,595 · 3
R03$157,678 · 1
Top collaborators
- Jeffrey M Collins2 shared
- Julia Alison Critchley2 shared
- Maia Kipiani2 shared
- Ashish Arunkumar Sharma2 shared
- Moises Arturo Huaman Joo1 shared
- Yan Sun1 shared
Most similar at Emory University
Same institution · by research overlap
- E. John Wherry$31,162,830
- Luisa Cervantes Barragan$2,421,990
- Jeffrey M Collins$2,659,365
- Sara Auld$4,352,467
- Henry M Blumberg$34,304,291
Others in their field
Other Emerging Leaders on “Tuberculosis”
- Kevin Urdahl · Seattle Children'S Hospital$86,597,961
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Yunda Huang · Fred Hutchinson Cancer Center$52,438,893
- Sarah Fortune · Harvard School Of Public Health$51,119,645
- Michael Dignam · National Institute Of Allergy And Infectious Diseases$31,845,607
- Jay Evans · University Of Montana$15,453,274
Research focus
TuberculosisCohortFutureTuberculosis TreatmentCessation Of LifeCountryInsulin ResistanceCommunicable DiseasesChronicPublic HealthProspectiveEpidemicDiabetes MellitusIncidenceDiabetes RiskInflammatoryPersonsGlucoseInflammationParticipantLow And Middle-Income CountriesObesityEnrollmentPrevent
Grant awards (14)
Tuberculosis infection and risk of diabetes mellitus and cardiovascular disease: Epigenetic and cardiometabolic trajectories after TB infection$821,087
R01 · FY2025 · AI · contact PI
Immunometabolic impact of stress hyperglycemia on tuberculosis treatment outcomes and risk of diabetes mellitus$749,831
R01 · FY2025 · AI · contact PI
Multiomics Characterization of Micobiome and Immunometabolic REmodeling in Tuberculosis Stress Hyperglycemia$227,708
R21 · FY2025 · AI
Immunometabolic impact of stress hyperglycemia on tuberculosis treatment outcomes and risk of diabetes mellitus$737,374
R01 · FY2024 · AI · contact PI
Multiomics Characterization of Micobiome and Immunometabolic REmodeling in Tuberculosis Stress Hyperglycemia$195,625
R21 · FY2024 · AI
Immunometabolic impact of stress hyperglycemia on tuberculosis treatment outcomes and risk of diabetes mellitus$726,653
R01 · FY2023 · AI · contact PI
Immunometabolic impact of stress hyperglycemia on tuberculosis treatment outcomes and risk of diabetes mellitus$727,159
R01 · FY2022 · AI · contact PI
The Role of Tuberculosis Disease on Non-Communicable Disease Risk: Comparative Analysis of Large Healthcare Databases$132,253
R21 · FY2022 · AI · contact PI
Immunometabolic impact of stress hyperglycemia on tuberculosis treatment outcomes and risk of diabetes mellitus$752,999
R01 · FY2021 · AI · contact PI
The Role of Tuberculosis Disease on Non-Communicable Disease Risk: Comparative Analysis of Large Healthcare Databases$240,091
R21 · FY2021 · AI · contact PI
Pulmonary impairment after tuberculosis in Georgia: Enhancing clinical research capacity to address the intersection of non-communicablediseases and tuberculosis$169,818
R21 · FY2020 · TW
Pulmonary impairment after tuberculosis in Georgia: Enhancing clinical research capacity to address the intersection of non-communicablediseases and tuberculosis$192,100
R21 · FY2019 · TW
Latent tuberculosis infection and risk of type 2 diabetes mellitus in US veterans$77,568
R03 · FY2019 · AI · contact PI
Latent tuberculosis infection and risk of type 2 diabetes mellitus in US veterans$80,110
R03 · FY2018 · AI · contact PI